161 related articles for article (PubMed ID: 2650100)
1. T-lymphocyte subsets: major histocompatibility antigens rejection of H-2K or H-2I region disparate skin allografts by either Lyt-2+ or L3T4+ T-lymphocyte subset.
Smith DM; McKisic M; Stuart FP; Fitch FW
Transplant Proc; 1989 Feb; 21(1 Pt 1):162-4. PubMed ID: 2650100
[No Abstract] [Full Text] [Related]
2. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC.
Rosenberg AS; Mizuochi T; Singer A
Nature; 1986 Aug 28-Sep 3; 322(6082):829-31. PubMed ID: 3528862
[TBL] [Abstract][Full Text] [Related]
3. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts.
Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW
Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046
[TBL] [Abstract][Full Text] [Related]
4. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
[No Abstract] [Full Text] [Related]
5. Anti-L3T4 monoclonal antibodies prolong survival of Ia-antigen disparate skin allografts.
Holán V
Folia Biol (Praha); 1988; 34(2):65-71. PubMed ID: 3294049
[TBL] [Abstract][Full Text] [Related]
6. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens.
Hamilton BL
J Immunol; 1987 Oct; 139(8):2511-5. PubMed ID: 3498761
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
[TBL] [Abstract][Full Text] [Related]
8. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
[TBL] [Abstract][Full Text] [Related]
9. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
Korngold R; Sprent J
J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of rejection of MHC class I-disparate murine skin grafts. III. Are L3T4+ T cells involved in the rejection?
Kobayashi E; Kawai K; Ikarashi Y; Watanabe H; Ito M; Fujiwara M
Transplant Proc; 1991 Jun; 23(3):2008-11. PubMed ID: 1676551
[No Abstract] [Full Text] [Related]
11. Distinct roles for L3T4 in T cell activation.
Greenstein JL; Sitkovsky MV; Burakoff SJ
Fed Proc; 1987 Feb; 46(2):313-6. PubMed ID: 3492395
[TBL] [Abstract][Full Text] [Related]
12. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
Maeda H; Ogoshi S; Fujimoto S
Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
[No Abstract] [Full Text] [Related]
14. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
Matoba AY; Peeler JS; Niederkorn JY
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
[TBL] [Abstract][Full Text] [Related]
15. Depletion of RT6+ T lymphocytes prolongs skin allograft in rats.
Chen-Woan M; Greiner DL; Mihalyo M; Schweizer RT
Transplant Proc; 1989 Feb; 21(1 Pt 1):165-8. PubMed ID: 2650101
[No Abstract] [Full Text] [Related]
16. Engraftment of allogeneic bone marrow following administration of anti-T cell monoclonal antibodies and low-dose irradiation.
Sharabi Y; Sachs DH
Transplant Proc; 1989 Feb; 21(1 Pt 1):233-5. PubMed ID: 2650109
[TBL] [Abstract][Full Text] [Related]
17. The T cell populations mediating rejection of MHC class I disparate skin grafts in mice.
Rosenberg AS
Transpl Immunol; 1993; 1(2):93-9. PubMed ID: 7915953
[No Abstract] [Full Text] [Related]
18. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
19. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
[TBL] [Abstract][Full Text] [Related]
20. Tolerance of skin allografts incompatible at the entire H-2 complex induced in adult mice by the post-transplant treatment.
Chutná J; Holán V; Sládecek M; Hasek M
Folia Biol (Praha); 1986; 32(2):154-8. PubMed ID: 3522287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
